Veru Inc.
NASDAQ: VERU0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mitchell S. Steiner
- Employees
- 210
- Headquarters
- Miami, United States
- IPO year
- 1999
- Market cap
- $47.7M
- Website
- https://www.verupharma.com
Loading VERU…
Loading profile data…Frequently asked questions about VERU
What does Veru Inc. (VERU) do?
Veru Inc. operates as a biopharmaceutical firm primarily dedicated to advancing novel therapeutic agents for various types of cancer. Commercially, Veru markets the FC2 internal condom, designed to offer dual protection against both unplanned pregnancies and the transmission of sexually transmitted infections. This product is distributed globall...
Where does VERU trade?
Veru Inc. (VERU) trades on the NASDAQ Capital Market.
What sector is VERU in?
Veru Inc. (VERU) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Veru Inc.?
Mitchell S. Steiner is the chief executive officer of Veru Inc. (VERU).
Where is Veru Inc. headquartered?
Veru Inc. is headquartered in United States.
Does VERU pay a dividend?
Veru Inc. (VERU) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VERU go public?
Veru Inc. (VERU) completed its initial public offering in 1999.